An Exploratory Investigation of Dietary Supplementation and the Effect on Common PMS and Menstrual Symptoms

Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Female, aged 18-40 * Willingness to refrain from ibuprofen or naproxen sodium (such as Advil, Aleve, Motrin or Midol) during each period (pill bleed) during the study * Ability to take oral medication and be willing to adhere to the dietary supplement regimen * Use of hormonal contraception for at least 3 months prior to screening and agreement to use such a method during study participation. Hormonal contraception must allow for pill bleeds to occur. * Moderate self-reported discomfort during menstruation related to bloating, pelvic cramps, fatigue or mood swings. On a scale of 1-10, participants must report at least a 4 on two or more symptoms. * Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration Exclusion Criteria: * Current use of GnRH agonists and antagonists including Lupron or Orilissa * Current use of an extended activity hormonal contraception (for example, Depo-provera or Nexplanon) * Current use of hyperthyroid medication such as methimazole * Current use of blood thinning medication * Pregnancy, lactation, or attempting to become pregnant during study * Known allergic reactions to components of the dietary supplement (sunflower oil, ashwagandha, curcumin, resveratrol, Boswellia, milk thistle, quercetin or catechins)